STAT Seeks Reporter to Cover Declining Trust in Science
STAT posted a job opening for a reporter to establish a new beat on declining trust in science. The role focuses on explanatory and investigative coverage of where trust is eroding and its effects on public health.
app.buzzsumo.comSTAT announced it is hiring a reporter to cover declining trust in science as a dedicated beat. The position will examine breakdowns in public confidence in scientific institutions and mainstream medicine. The job description lists topics including vaccine skepticism, misinformation, conflicts of interest, scientific misconduct, and the influence of social media and political polarization.
The reporter will also investigate individuals and businesses that profit from reduced confidence in science. Responsibilities include producing enterprise and investigative stories, breaking news on the topic, and seeking sources across a range of perspectives. The role requires at least five years of reporting experience and the ability to explain complex scientific and policy issues clearly.
The annual salary range for the position is listed as $74,911 to $120,000. The posting states the role is based anywhere in the United States and is covered by a collective bargaining agreement with the Boston Newspaper Guild. STAT is affiliated with Boston Globe Media Partners but operates independently from The Boston Globe.
The organization produces daily news, investigative articles, and multimedia content focused on health, medicine, and life sciences.
Key Facts
Potential Impact
- 01
STAT may publish additional enterprise and investigative stories on the beat.
- 02
The new position may increase the volume of coverage on trust in science topics.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…